Hikari Tsushin Inc. reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 17.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 12,530 shares of the medical equipment provider’s stock after selling 2,655 shares during the quarter. Intuitive Surgical makes up about 0.3% of Hikari Tsushin Inc.’s investment portfolio, making the stock its 26th largest holding. Hikari Tsushin Inc.’s holdings in Intuitive Surgical were worth $5,095,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in ISRG. E Fund Management Hong Kong Co. Ltd. lifted its holdings in shares of Intuitive Surgical by 53.2% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 3,046 shares of the medical equipment provider’s stock valued at $1,239,000 after buying an additional 1,058 shares during the last quarter. Sumitomo Life Insurance Co. grew its stake in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Sumitomo Life Insurance Co. now owns 31,734 shares of the medical equipment provider’s stock valued at $12,904,000 after buying an additional 1,248 shares in the last quarter. Whittier Trust Co. increased its holdings in Intuitive Surgical by 9.6% in the third quarter. Whittier Trust Co. now owns 150,194 shares of the medical equipment provider’s stock worth $63,676,000 after buying an additional 13,217 shares during the last quarter. Saranac Partners Ltd increased its holdings in Intuitive Surgical by 2.9% in the third quarter. Saranac Partners Ltd now owns 18,404 shares of the medical equipment provider’s stock worth $7,951,000 after buying an additional 524 shares during the last quarter. Finally, Patron Partners LLC increased its holdings in Intuitive Surgical by 11.0% in the third quarter. Patron Partners LLC now owns 3,005 shares of the medical equipment provider’s stock worth $1,222,000 after buying an additional 298 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Intuitive Surgical
In other news, SVP Patricia L. Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the transaction, the director directly owned 1,150 shares in the company, valued at approximately $529,000. This represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 39,363 shares of company stock worth $17,738,749. 0.60% of the stock is currently owned by company insiders.
Intuitive Surgical Price Performance
Shares of NASDAQ:ISRG opened at $399.06 on Friday. The stock has a market capitalization of $138.33 billion, a P/E ratio of 48.25, a P/E/G ratio of 3.02 and a beta of 1.45. The business has a 50-day moving average of $423.51 and a two-hundred day moving average of $427.91. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.40 EPS. As a group, research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.
Trending Headlines about Intuitive Surgical
Investors following ISRG have been watching these headlines:
- Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
- Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
Wall Street Analyst Weigh In
ISRG has been the topic of several recent research reports. Mizuho cut their price objective on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 21st. BTIG Research boosted their target price on shares of Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a research report on Wednesday. Wells Fargo & Company reissued an “overweight” rating and issued a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research note on Tuesday. Finally, Barclays restated an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $495.90.
Read Our Latest Report on ISRG
About Intuitive Surgical
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
